Nano-x Imaging (NASDAQ:NNOX) Surges 26.38% on $15M Capital Raise, Boosting AI Expansion and Market Reach

Nano-x Imaging Ltd. (NASDAQ: NNOX) surged 26.3768% in pre-market trading on November 24, 2025, following a $15 million capital raise through a registered direct offering of 3.826 million shares. The proceeds will bolster the company’s balance sheet and accelerate growth initiatives, including AI infrastructure expansion and market penetration.

The offering, led by Titan Partners Group as sole placement agent, is set to close by November 25, 2025. Funds will prioritize working capital and general corporate purposes, with CEO Erez Meltzer emphasizing the strategic use of capital to advance the company’s medical imaging technologies and cloud-based platforms. The transaction leverages an effective SEC-registered Form F-3 shelf statement filed in May 2023.

Nano-x’s ecosystem includes the Nanox.ARC tomosynthesis system, AI-driven imaging algorithms, and teleradiology services via USARAD Holdings. Recent partnerships, such as the collaboration with Monarch Medical Management, aim to expand its healthcare network. Analysts note the stock’s low valuation multiples despite recent volatility, suggesting potential undervaluation amid its growth trajectory.

A hypothetical buy-and-hold strategy initiated in early 2025, based on the company’s capital-raising announcements and AI-driven growth focus, could align with the recent pre-market surge. A trailing stop-loss of 15% might mitigate downside risk while capturing momentum from key catalysts like regulatory approvals or partnership expansions. Performance would hinge on execution of the $15 million funding’s intended use and market adoption of its AI-enhanced imaging solutions.